Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | $77.9M | $134.7M | $195.4M | $292.8M | $380.5M | $575.6M |
| Cost of revenue | $18.1M | $28.7M | $39.2M | $45.2M | $59.2M | $84.2M |
| Gross profit | $59.8M | $106.1M | $156.2M | $247.6M | $321.3M | $491.3M |
| Gross margin | 76.7% | 78.7% | 79.9% | 84.6% | 84.4% | 85.4% |
| R&D | $7.4M | $9.6M | $11.8M | $25.4M | $33.2M | $41.6M |
| Operating income | −$38.1M | −$36.8M | −$24.8M | −$38.0M | $12.2M | $38.0M |
| EBITDA | −$28.1M | −$20.2M | −$2.5M | −$10.0M | $42.5M | $81.1M |
| Net income | −$41.7M | −$34.1M | −$28.1M | −$149.7M | $1.5M | $59.0M |
| Net margin | -53.5% | -25.3% | -14.4% | -51.1% | 0.4% | 10.2% |
| EPS (diluted) | -0.06 | -0.05 | -0.04 | -0.23 | 0.00 | 0.09 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.0B | $0.24 | $0.24–$0.24 | 1 |
| 2027 | $1.3B | $0.29 | $0.29–$0.29 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds DRKTF.
No tracked institution reports a position in DRKTF as of their last filing.
No one on the platform has traded DRKTF yet.
| $2.3B |
| — |
| FXCOFFoxconn Technology Co., Ltd. | $1.76 | +0.00% | $2.5B | — |
| IDXAFIDEX Biometrics ASA | $0.89 | +0.00% | $69M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 5.5× sales vs its 8.7× historical median P/S.
Fair value ≈ $4.77 · price $3.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.